KONTAN.CO.ID - JAKARTA. Indonesia's investment authority (INA) and China's Silk Road Fund (SRF) said on Thursday they have subscribed to pharmaceutical company Kimia Farma's convertible bonds. The investment aims to accelerate healthcare access across Indonesia, INA CEO Ridha Wirakusumah said in a statement. Both INA, which is Indonesia's sovereign wealth fund, and SRF also acquired 40% shares of Kimia Farma's unit Kimia Farma Apotek (KFA), according to the statement.
INA, China Silk Road Fund Subscribe to Kimia Farma's Convertible Bonds
KONTAN.CO.ID - JAKARTA. Indonesia's investment authority (INA) and China's Silk Road Fund (SRF) said on Thursday they have subscribed to pharmaceutical company Kimia Farma's convertible bonds. The investment aims to accelerate healthcare access across Indonesia, INA CEO Ridha Wirakusumah said in a statement. Both INA, which is Indonesia's sovereign wealth fund, and SRF also acquired 40% shares of Kimia Farma's unit Kimia Farma Apotek (KFA), according to the statement.